Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2000
03/02/2000WO2000011166A1 14274 receptor, a g-protein coupled receptor related to the edg receptor family
03/02/2000WO2000011165A1 ROLE OF HUMAN KIS (hKIS) AS AN INHIBITORY KINASE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P27. COMPOSITIONS, METHODS AND USES THEREOF TO CONTROL CELL PROLIFERATION
03/02/2000WO2000011164A1 Human angiopoietin-3
03/02/2000WO2000011163A1 Dcr5, a bmp-binding protein, and applications thereof
03/02/2000WO2000011162A1 Modulation of apoptosis with bid
03/02/2000WO2000011161A1 Novel collectin
03/02/2000WO2000011160A1 Grip, human adapter protein related to the grb2 family member
03/02/2000WO2000011159A1 Pharmaceutical composition for treating or preventing diabetes or cancer, or the waardenburg syndrome
03/02/2000WO2000011158A1 Genetically modified and diabetic non-human animal
03/02/2000WO2000011156A1 Method for isolating satellite sequence
03/02/2000WO2000011155A1 Methods and compositions for genomic modification
03/02/2000WO2000011154A1 USE OF SUPPRESSOR tRNA'S TO REGULATE CYTOTOXICITY DURING THE PRODUCTION OF RECOMBINANT GENE PRODUCTS
03/02/2000WO2000011153A1 Monoclonal antibody inhibiting the liberation of cell atp and hybridomas producing the monoclonal antibody
03/02/2000WO2000011152A1 Streptavidin mutants having secondary functional domains
03/02/2000WO2000011151A2 Direct oviduct transgenesis
03/02/2000WO2000011149A1 Methods of producing high titer recombinant adeno-associated virus
03/02/2000WO2000011148A2 Cold-shock regulatory elements, constructs thereof, and methods of use
03/02/2000WO2000011146A1 Artiodactyl epimorphine
03/02/2000WO2000011145A1 Apparatus for extracting and processing gene motif, method for extracting and processing gene motif and recording medium carrying gene motif extraction/processing program
03/02/2000WO2000011144A2 Plastid-targeting nucleic acid sequence, beta-amylase sequence, a stimulus-responsive promoter and uses thereof
03/02/2000WO2000011138A1 Salt-tolerant transgenic turfgrass
03/02/2000WO2000011034A1 A mutant of tissue factor pathway inhibitor, dna sequence and use for detecting thrombotic disorders
03/02/2000WO2000011033A2 Expression and export of angiostatin and endostatin as immunofusins
03/02/2000WO2000011025A1 Modified synthetic dna sequences for improved insecticidal control
03/02/2000WO2000011019A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agent
03/02/2000WO2000011018A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents
03/02/2000WO2000011015A1 Secreted proteins and polynucleotides encoding them
03/02/2000WO2000011014A1 49 human secreted proteins
03/02/2000WO2000011013A1 Modified nucleomonomers and methods of use thereof
03/02/2000WO2000011012A1 Synthetic fatty acid desaturase gene for expression in plants
03/02/2000WO2000010612A1 Methods to enhance and confine expression of genes
03/02/2000WO2000010608A1 Preventives/remedies for arteriosclerosis and post-ptca reangiostenosis
03/02/2000WO2000010603A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000WO2000010602A1 Lats knock-out animal models and their uses
03/02/2000WO2000010599A2 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
03/02/2000WO2000010594A1 The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives
03/02/2000WO2000010588A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
03/02/2000WO2000010583A1 Human histone deacetylase gene hd4
03/02/2000WO2000010582A2 Probiotic, lactic acid-producing bacteria and uses thereof
03/02/2000WO2000010579A1 Method for detection of biological factors in epidermis
03/02/2000WO2000010578A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE
03/02/2000WO2000010389A1 BLOCKADE OF GLUCOSE TOXICITY TO THE β CELLS IN THE ISLETS OF LANGERHANS
03/02/2000WO2000010384A1 Nonhuman animals with disruption of cmp-n-acetylneuraminate hydroxylase gene
03/02/2000WO2000010383A1 Method for modifying chromosomes
03/02/2000WO2000010382A1 Model animal with visualized nerve network
03/02/2000WO2000010380A1 Manipulation of tocopherol levels in transgenic plants
03/02/2000WO1999066055A3 Plant pathogen inducible control sequences operably linked to cell cycle genes and the uses thereof
03/02/2000WO1999066049A3 A novel gene and method of treating a gram negative bacterial infection
03/02/2000WO1999065511A3 Composition and method for treatment of pseudomonas infection
03/02/2000WO1999064619A3 Novel mannanases
03/02/2000WO1999063938A9 Composition and method for prevention and treatment of cardiopulmonary and renal failure or damage associated with ischemia, endotoxin release, ards or brought about by administration of certain drugs
03/02/2000WO1999063116A3 Use of prothymosin in the diagnosis and treatment of endometriosis
03/02/2000WO1999063093A3 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
03/02/2000WO1999063090A3 Protease inhibitor peptides
03/02/2000WO1999061651A3 Methods for producing a polypeptide by modifying the copy number of a gene
03/02/2000WO1999061635A3 Cotton cells, plants, and seeds genetically engineered to express insecticidal and fungicidal chitin binding proteins (lectins)
03/02/2000WO1999061620A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
03/02/2000WO1999061614A3 Human socs proteins
03/02/2000WO1999061604A3 A vector for gene trap, and a method for gene trapping by using the vector
03/02/2000WO1999060126A3 Protein z-dependent protease inhibitor
03/02/2000WO1999060124A9 Differentiation-associated sequences and methods of use therefor
03/02/2000WO1999060103A3 Galactosyltransferase from plants involved in galactomannan biosynthrsis
03/02/2000WO1999058642A3 Secreted proteins and polynucleotides encoding them
03/02/2000WO1999058558A3 Cell signaling proteins
03/02/2000WO1999058552A3 Peptides that ellicit t, cellular immunity
03/02/2000WO1999057271A3 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
03/02/2000WO1999057263A9 Modifying the expression of the fsh beta gene by homologous recombination
03/02/2000WO1999057261A3 Human bmp-2 promoter and method for exploring bone-related substance by using the same
03/02/2000WO1999057149A3 Compounds and methods for modulating nonclassical cadherin-mediated functions
03/02/2000WO1999055862A3 Human proteins having transmembrane domains and dnas encoding these proteins
03/02/2000WO1999055367A9 INTERNALIZING ErbB2 ANTIBODIES
03/02/2000WO1999054465A3 Gene encoding syntaxin interacting protein
03/02/2000WO1999052563A9 A method for the targeting of proteins produced by yersinia into the cytosol of eukaryotic cells
03/02/2000WO1999050411A3 Tumour-specific expression control region and the use thereof
03/02/2000WO1999049083A9 Diagnosis of disease state using mrna profiles in peripheral leukocytes
03/02/2000WO1999049052A3 Processive glycosyltransferase
03/02/2000WO1999049043A3 Human rad17 cell cycle checkpoint
03/02/2000WO1999049024A8 Methods and compositions for production of multimeric proteins in transgenic plants
03/02/2000WO1999047668A3 Nucleic acid which codes for tumor suppressor proteins, tumor suppressor proteins, a method for the production thereof, an antibody against tumor suppressor proteins, and the use of these substances
03/02/2000WO1999045108A3 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
03/02/2000WO1999045031A3 Cd147 binding molecules as therapeutics
03/02/2000WO1999042596A3 Phosphodiesterase 10
03/02/2000WO1999037756A8 Non-human animal having a functionally disrupted slp-76 gene
03/02/2000WO1999036535A9 Apo-2 ligand
03/02/2000WO1999024578A3 Neisserial antigens
03/02/2000DE19940751A1 Apparatus for detecting light emissions comprises light-emitting matrix facing light-detection matrix, which together sandwich test substance
03/02/2000DE19839736A1 Humane monoklonale Antikörper gegen Inselzellantigen IA-2 Human monoclonal antibodies against islet cell antigen IA-2
03/02/2000DE19839491A1 Verfahren zur Markierung von Biopolymeren mit Isotopen Methods for labeling of biopolymers with isotopes
03/02/2000DE19839096A1 A cytokine-inducible gene and related protein useful for modulation of interferon gamma
03/02/2000DE19838837A1 Zellspezifische Promoter des Entkopplungsproteins 3 Cell-specific promoter of uncoupling protein 3
03/02/2000DE19836405C1 Transgene Pflanzen und Pflanzenzellen mit verminderter Expression von Invertaseinhibitoren Transgenic plants and plant cells with reduced expression of invertase
03/02/2000DE19827457C1 Strukturprotein von AAV, seine Herstellung und Verwendung AAV structural protein, its preparation and use
03/02/2000DE19816894C1 SREBP-2-defiziente Zellinien SREBP-2-deficient cell lines
03/02/2000CA2839037A1 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation
03/02/2000CA2341637A1 Chlamydia antigens and corresponding dna fragments and uses thereof
03/02/2000CA2341558A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000CA2341516A1 Cationic complexes of polymer-modified adenovirus
03/02/2000CA2341483A1 Use of pooled probes in genetic analysis
03/02/2000CA2341309A1 Use of mcrp for delivery of materials into cells
03/02/2000CA2341278A1 Modified synthetic dna sequences for improved insecticidal control
1 ... 3277 3278 3279 3280 3281 3282 3283 3284 3285 3286 3287 3288 3289 3290 3291 3292 3293 3294 3295 3296 3297 ... 4023